MedTrace Logo

Telemedicine or Standard Care in Treating Patients With Depression and/or Pain Caused By Cancer

NCT00313573 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 480

Last updated 2013-09-20

No results posted yet for this study

Summary

RATIONALE: Telemedicine may help in the treatment of depression and/or pain caused by cancer. It is not yet known whether telemedicine is more effective than standard care in treating depression and/or pain caused by cancer.

PURPOSE: This phase III randomized clinical trial is studying telemedicine to see how well it works compared to standard care in treating patients with depression and/or pain caused by cancer.

Conditions

Interventions

PROCEDURE

management of therapy complications

PROCEDURE

pain therapy

PROCEDURE

psychosocial assessment and care

PROCEDURE

quality-of-life assessment

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Indiana University Melvin and Bren Simon Cancer Center

    lead OTHER

Principal Investigators

  • Kurt Kroenke, MD · Regenstrief Institute, Incorporated

Study Design

Allocation
RANDOMIZED

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00313573 on ClinicalTrials.gov